Patent application number | Description | Published |
20130314272 | DETECTION OF RADAR OBJECTS WITH THE AID OF A RADAR SENSOR OF A MOTOR VEHICLE - A method and a system for detecting radar objects with the aid of an angle-resolving radar sensor of a motor vehicle in the presence of an object which extends in the driving direction laterally next to the motor vehicle's own lane and reflects radar waves, a measured position distribution which corresponds to a distribution of azimuth angles of received radar signals of the radar sensor reflected off a radar object being compared to a model of a position distribution which is expected taking into account the presence of the object extending in the driving direction next to the vehicle's own lane, and is a function of a distance from the radar object and a position of a radar object being determined based on the result of the comparison. | 11-28-2013 |
20130335260 | ASCERTAINING AN INDICATOR FOR THE DRIVE-OVER CAPABILITY OF AN OBJECT - In a method for ascertaining whether a target object can be driven over by the controlled motor vehicle, with the aid of frequency-modulated radar signals of a radar sensor, amplitude ratios between received radar signals reflected from the target object are utilized, the received radar signals corresponding to signals which have been transmitted in different frequency ranges. Based on the amplitude ratios, an occurrence of interference between (i) a first radar signal propagation path between the radar sensor and the target object and (ii) a second propagation path with additional reflection from a road is detected, and based on the detection of an occurrence of interference it is ascertained whether the object can be driven over. | 12-19-2013 |
20140022111 | DETECTION OF RADAR OBJECTS USING A RADAR SENSOR OF A MOTOR VEHICLE - In a method for detecting radar objects with the aid of a radar sensor of a motor vehicle, a transmitted signal has a sequence of frequency modulations, to each of which a partial signal of a measuring signal is assigned; first information about the relative velocity and the distance of a radar object is ascertained based on a frequency spectrum of at least one of the partial signals; second information about the relative velocity and the distance of the radar object is ascertained based on a frequency spectrum of a time curve of values of frequency spectra of the partial signals at a frequency position of the radar object in these frequency spectra; and the relative velocity and the distance of the radar object are ascertained based on matching of the first information with the second information. | 01-23-2014 |
20140253365 | METHOD FOR CYCLICALLY MEASURING DISTANCES AND VELOCITIES OF OBJECTS USING AN FMCW RADAR SENSOR - In a method for cyclically measuring distances (d) and relative velocities (v) of objects using an FMCW radar sensor, the frequency (f) of a transmitted signal of the radar sensor is periodically modulated, each period (P) including at least two differing modulation patterns, a relationship between distance (d) and velocity (v) of the object being derived from a signal received for a single modulation pattern, and the signals received for multiple modulation patterns being adjusted to one another in order to determine one value each for the distance and the velocity per each measuring cycle. For the adjustment between a signal obtained for a modulation pattern in the instantaneous measuring cycle and the signal(s) obtained for other modulation patterns, the signals from at least one previous measuring cycle are utilized. | 09-11-2014 |
20140347208 | Method for evaluating obstacles in a driver assistance system for motor vehicles - A method for evaluating obstacles based on locating data of a radar sensor in a driver assistance system for motor vehicles, in which at least one evaluation function is calculated which indicates, as a function of a set of measured variables which are related to a potential obstacle, whether the potential obstacle is to be evaluated as a real obstacle, a complexity indicator being formed based on the locating data which indicates the complexity of a present measurement situation, and at least two different evaluation functions being defined for the same set of measured variables, and it being decided which of the evaluation functions is applied in the present measurement situation as a function of the complexity indicator. | 11-27-2014 |
20140347211 | METHOD FOR OPERATING A MIMO RADAR - In a method for operating a MIMO radar, an influence of an object motion on an angle estimate is substantially eliminated, and a time multiplex schema having a transmission sequence and transmission instants of transmitters of the MIMO radar is identified by optimizing the following mathematical relationship: | 11-27-2014 |
20140354467 | ANGLE-RESOLVING RADAR SENSOR - An angle-resolving radar sensor, e.g., for motor vehicles, includes : an antenna having multiple antenna elements which are each switchable to one of multiple evaluation channels; and an evaluation device for determining the angle of incidence of a received signal based on the amplitudes measured in the evaluation channels. The number of antenna elements is greater than the number of evaluation channels and a switching device is provided to connect the evaluation channels alternatingly to different selections of antenna elements. | 12-04-2014 |
20150048970 | ANGULARLY RESOLVING RADAR SENSOR - An angularly resolving radar sensor having multiple antenna elements that, in a direction in which the radar sensor is angularly resolving, are disposed in different positions, and having a control and evaluation device that is designed for an operating mode in which several of the antenna elements transmit signals that are respectively received by several of the antenna elements, and the angle (θ) of a located object is identified on the basis of amplitudes and/or phase relationships between signals which correspond to different configurations of transmitting and receiving antenna elements, wherein the control and evaluation device is embodied to supply several of the transmitting antenna elements simultaneously with identical-frequency signals (f | 02-19-2015 |
Patent application number | Description | Published |
20090123489 | NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 11 novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses. | 05-14-2009 |
20090136528 | NOVEL IMMUNOGENIC EPITOPE FOR IMMUNOTHERAPY - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. The present invention relates to novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumour cells which can be used in vaccine compositions for eliciting anti-tumour immune responses. | 05-28-2009 |
20090148400 | COMPOSITION OF TUMOUR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE - The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumour immune responses against colorectal cancer. | 06-11-2009 |
20100158931 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses. | 06-24-2010 |
20110002963 | COMPOSITION OF TUMOR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE FOR THE TREATMENT OF GLIOBLASTOMA (GBM) AND OTHER CANCERS - The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gliomas. | 01-06-2011 |
20110070253 | TUMOUR-ASSOCIATED PEPTIDES BINDING TO MHC MOLECULES - The invention relates to a tumour-associated peptide with an amino acid sequence that is selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 101 of the attached sequence protocol, wherein the peptide has the ability to bind to a molecule of the human major-histocompatibility-complex (MHC) class-I. In addition, the invention relates to the use of the peptides and the nucleic acids encoding for the peptides for the production of a medicament, and for the treatment of tumorous diseases and/or adenomatous diseases. Furthermore, a pharmaceutical composition is described that has at least one of the peptides. | 03-24-2011 |
20110117117 | NOVEL IMMUNOGENIC EPITOPES FOR IMMUNOTHERAPY - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. The present invention relates to novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumour cells which can be used in vaccine compositions for eliciting anti-tumour immune responses. | 05-19-2011 |
20130004456 | COMPOSITION OF TUMOR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE FOR THE TREATMENT OF GLIOBLASTOMA (GBM) AND OTHER CANCERS - The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gliomas. | 01-03-2013 |
20130309193 | COMPOSITION OF TUMOR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE FOR THE TREATMENT OF GLIOBLASTOMA (GBM) AND OTHER CANCERS - The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gliomas. | 11-21-2013 |
20140271692 | NOVEL IMMUNOGENIC EPITOPES FOR IMMUNOTHERAPY - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. The present invention relates to novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumour cells which can be used in vaccine compositions for eliciting anti-tumour immune responses. | 09-18-2014 |
Patent application number | Description | Published |
20110229505 | Methods for the diagnosis and treatment of cancer based on AVL9 - The present invention relates to methods for the diagnosis and treatment of cancer in mammals, in particular gastric cancer, based on the new target AVL9. The present invention thus relates to diagnostic methods and related components to be used in such methods. Furthermore, the present invention relates to the treatment of cancer in mammals, in particular gastric cancer, based on AVL9 as a target. Specifically, the present invention relates to the immunotherapy of cancer using AVL9 tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides, and respective pharmaceutical compositions, in particular vaccine compositions. | 09-22-2011 |
20120141517 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses. | 06-07-2012 |
20140086943 | NOVEL AND POWERFUL MHC-CLASS II PEPTIDES DERIVED FROM SURVIVIN - The present invention relates to peptides, nucleic acids, and cells for use in the immunotherapy of cancer. The present invention furthermore relates to survivin-derived tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention specifically relates to three novel peptide sequences and variants thereof derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses. | 03-27-2014 |